Does long-acting injectable risperidone make a difference to the real-life treatment of schizophrenia? Results of the Cohort for the General study of Schizophrenia (CGS). (Q39680993)
Jump to navigation
Jump to search
scientific article published on 30 November 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Does long-acting injectable risperidone make a difference to the real-life treatment of schizophrenia? Results of the Cohort for the General study of Schizophrenia (CGS). |
scientific article published on 30 November 2011 |
Statements
1 reference
Does long-acting injectable risperidone make a difference to the real-life treatment of schizophrenia? Results of the Cohort for the General study of Schizophrenia (CGS). (English)
1 reference
Lamiae Grimaldi-Bensouda
1 reference
Frederic Rouillon
1 reference
Bernard Astruc
1 reference
Michel Rossignol
1 reference
Jacques Benichou
1 reference
Frederic Limosin
1 reference
Beatrice Beaufils
1 reference
Guillaume Vaiva
1 reference
Helene Verdoux
1 reference
Yola Moride
1 reference
Alban Fabre
1 reference
Florence Thibaut
1 reference
Lucien Abenhaim
1 reference
CGS Study Group
1 reference
30 November 2011
1 reference
1 reference
134
1 reference
2-3
1 reference
187-194
1 reference
Identifiers
1 reference
1 reference